Clin Psychopharmacol Neurosci . Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report

[tetano]

Clin Psychopharmacol Neurosci


. 2022 Nov 30;20(4):777-780.
doi: 10.9758/cpn.2022.20.4.777.
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report


Pricilla Yani Gunawan ^{1 2} , Pamela Tiffani ¹ , Lilie Lalisang ^{1 2}



Affiliations

• PMID: 36263653
• DOI: 10.9758/cpn.2022.20.4.777

Abstract

After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.

Keywords: Facial paralysis; Guillain-Barre syndrome; SARS-CoV-2; Vaccination.